Rebound has acquired NOCD, the leading telehealth provider for obsessive-compulsive disorder (OCD) treatment, for an undisclosed amount. This strategic move sees Rebound integrate NOCD's specialized platform, which offers clinically proven care for one of the most severe and misunderstood mental health conditions.
NOCD operates an innovative telehealth platform, providing access to online therapy for individuals with OCD. Through its dedicated app, members can schedule and engage in live, face-to-face video therapy sessions with a national network of licensed therapists. These specialists deliver Exposure and Response Prevention Therapy (ERP), recognized as the "gold standard" in OCD treatment. Beyond scheduled sessions, NOCD supports patients with 24/7 access to self-help tools and peer communities, aiming to remove barriers to care and reduce stigma.
The acquisition is poised to significantly enhance Rebound's presence in the specialized mental health sector. By integrating NOCD's focused expertise and established telehealth infrastructure, Rebound gains a robust platform for addressing OCD, a condition often underserved by general mental health services. This synergy is expected to broaden access to high-quality, evidence-based OCD treatment, leveraging NOCD's proven clinical model and patient support systems within Rebound's broader operational framework.
This acquisition underscores a commitment to expanding access to specialized mental healthcare. The combined entity is expected to accelerate the delivery of effective OCD treatment, reaching more individuals in need and further solidifying its position in the evolving telehealth landscape.